Suppr超能文献

病理性 tau 和反应性星形胶质细胞增生与 tau 病小鼠模型中的特定功能缺陷有关。

Pathological tau and reactive astrogliosis are associated with distinct functional deficits in a mouse model of tauopathy.

机构信息

Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Anatomy, Cell Biology & Physiology, Indiana University School of Medicine, Indianapolis, IN, USA.

Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA.

出版信息

Neurobiol Aging. 2022 Jan;109:52-63. doi: 10.1016/j.neurobiolaging.2021.09.006. Epub 2021 Sep 20.

Abstract

Pathological aggregation of tau and neuroinflammatory changes mark the clinical course of Alzheimer's disease and related tauopathies. To understand the correlation between these pathological hallmarks and functional deficits, we assessed behavioral and physiological deficits in the PS19 mouse model, a broadly utilized model of tauopathy. At 9 months, PS19 mice have characteristic hyperactive behavior, a decline in motor strength, and deterioration in physiological conditions marked by lower body temperature, reduced body weight, and an increase in measures of frailty. Correlation of these deficits with different pathological hallmarks revealed that pathological tau species, characterized by soluble p-tau species, and tau seeding bioactivity correlated with impairment in grip strength and thermal regulation. On the other hand, astrocyte reactivity showed a positive correlation with the hyperactive behavior of the PS19 mice. These results suggest that a diverse spectrum of soluble pathological tau species could be responsible for different symptoms and that neuroinflammation could contribute to functional deficits independently from tau pathology. These observations enhance the necessity of a multi-targeted approach for the treatment of neurodegenerative tauopathies.

摘要

tau 蛋白病理性聚集和神经炎症变化标志着阿尔茨海默病及相关 tau 病的临床进程。为了理解这些病理特征与功能缺陷之间的相关性,我们评估了 PS19 小鼠模型(一种广泛应用的 tau 病模型)的行为和生理缺陷。在 9 个月时,PS19 小鼠表现出特征性的过度活跃行为、运动力量下降以及生理状况恶化,表现为体温降低、体重减轻和脆弱性增加。这些缺陷与不同病理特征的相关性表明,可溶性 p-tau 物种和 tau 种子生物活性等病理性 tau 物种与握力和体温调节受损相关。另一方面,星形胶质细胞反应与 PS19 小鼠的过度活跃行为呈正相关。这些结果表明,不同的可溶性病理性 tau 物种可能导致不同的症状,神经炎症可能独立于 tau 病理学导致功能缺陷。这些观察结果增强了针对神经退行性 tau 病采用多靶点治疗方法的必要性。

相似文献

1
Pathological tau and reactive astrogliosis are associated with distinct functional deficits in a mouse model of tauopathy.
Neurobiol Aging. 2022 Jan;109:52-63. doi: 10.1016/j.neurobiolaging.2021.09.006. Epub 2021 Sep 20.
2
Chronic Social and Psychological Stress Impact Select Neuropathologies in the PS19 Mouse Model of Tauopathy.
Psychosom Med. 2024 Jun 1;86(5):366-378. doi: 10.1097/PSY.0000000000001256. Epub 2023 Oct 3.
4
Inhibition of Calpain Protects Against Tauopathy in Transgenic P301S Tau Mice.
J Alzheimers Dis. 2019;69(4):1077-1087. doi: 10.3233/JAD-190281.
5
A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Exp Neurol. 2008 Jul;212(1):71-84. doi: 10.1016/j.expneurol.2008.03.007. Epub 2008 Mar 21.
6
Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies.
Acta Neuropathol. 2015 Nov;130(5):619-31. doi: 10.1007/s00401-015-1483-3. Epub 2015 Oct 6.
7
Inpp5d haplodeficiency alleviates tau pathology in the PS19 mouse model of Tauopathy.
Alzheimers Dement. 2024 Jul;20(7):4985-4998. doi: 10.1002/alz.14078. Epub 2024 Jun 26.
9
The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
Neurobiol Aging. 2017 Jan;49:40-51. doi: 10.1016/j.neurobiolaging.2016.09.006. Epub 2016 Sep 15.
10

引用本文的文献

2
6
Evaluation of Alpha-Synuclein and Tau Antiaggregation Activity of Urea and Thiourea-Based Small Molecules for Neurodegenerative Disease Therapeutics.
ACS Chem Neurosci. 2024 Nov 6;15(21):3915-3931. doi: 10.1021/acschemneuro.4c00282. Epub 2024 Oct 22.
9
Inpp5d haplodeficiency alleviates tau pathology in the PS19 mouse model of Tauopathy.
Alzheimers Dement. 2024 Jul;20(7):4985-4998. doi: 10.1002/alz.14078. Epub 2024 Jun 26.

本文引用的文献

2
Reactive astrocyte nomenclature, definitions, and future directions.
Nat Neurosci. 2021 Mar;24(3):312-325. doi: 10.1038/s41593-020-00783-4. Epub 2021 Feb 15.
3
Lowering Synaptogyrin-3 expression rescues Tau-induced memory defects and synaptic loss in the presence of microglial activation.
Neuron. 2021 Mar 3;109(5):767-777.e5. doi: 10.1016/j.neuron.2020.12.016. Epub 2021 Jan 19.
4
Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer's Disease.
Cell. 2020 Dec 10;183(6):1699-1713.e13. doi: 10.1016/j.cell.2020.10.029. Epub 2020 Nov 13.
5
Tau at the interface between neurodegeneration and neuroinflammation.
Genes Immun. 2020 Nov;21(5):288-300. doi: 10.1038/s41435-020-00113-5. Epub 2020 Oct 3.
8
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease.
Nat Med. 2020 Aug;26(8):1256-1263. doi: 10.1038/s41591-020-0938-9. Epub 2020 Jun 22.
9
Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration.
J Clin Invest. 2020 Sep 1;130(9):4954-4968. doi: 10.1172/JCI138179.
10
Microglial activation and tau burden predict cognitive decline in Alzheimer's disease.
Brain. 2020 May 1;143(5):1588-1602. doi: 10.1093/brain/awaa088.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验